Sonidegib Tolerability Across 30-Months: Results from the Phase 2 Randomized BOLT Trial

Eggert Stockfleth

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility